title: The sensitivity of chemioresistant human tumor explants to lysis by activated and nonactivated autological lymphocytes: a pilot study.
abstract: OBJECTIVE
  The comparative study of antitumor action of peripheral blood lymphocytes (PBL) and lymphokin-activated killer cells (LAK) on autologous cell of chemoresistant and chemosensitive human soft tissue sarcomas and tumors of epithelial origin.
  
  
  METHODS
  Tumor explants (15 samples of soft tissue sarcomas, 10 samples of cervical and ovarian carcinomas) were cultivated with autologous lymphocytes in double diffusion chambers. Evaluation of the results was done on the basis of morphological criteria of explants growth.
  
  
  RESULTS
  The results have shown that in the patients with the resistant soft tissue sarcomas and carcinomas LAK possess more pronounced antitumor action, than non-activated lymphocytes, whilst PBL possess higher antitumor action on sensitive epithelial tumors than that on soft tissue sarcoma.
  
  
  CONCLUSIONS
  LAK possess antitumor action toward chemoresistant tumors of different origin and localization.
authors.affiliation: R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine. berezh@onconet.kiev.ua
authors.forename: N M
authors.initials: NM
authors.lastname: Berezhnaya
authors.forename: U D
authors.initials: UD
authors.lastname: Vinnichuk
authors.forename: V F
authors.initials: VF
authors.lastname: Konovalenko
authors.forename: L I
authors.initials: LI
authors.lastname: Vorobjova
authors.forename: O B
authors.initials: OB
authors.lastname: Belova
authors.forename: L A
authors.initials: LA
authors.lastname: Proskurnia
mesh_terms: D000328:Adult; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D019008:Drug Resistance, Neoplasm / Q000276:immunology*; D005260:Female; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D008213:Lymphocyte Activation / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology*; D008875:Middle Aged; D009375:Neoplasms, Glandular and Epithelial / Q000276:immunology*; D010051:Ovarian Neoplasms / Q000276:immunology; D010865:Pilot Projects; D012509:Sarcoma / Q000276:immunology*; D012983:Soft Tissue Neoplasms / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000276:immunology